Kanabo Research

Kanabo is a pioneering company in the medical cannabis industry, dedicated to creating a holistic ecosystem that enhances the well-being of millions globally. The company focuses on the distribution of cannabis-derived products for medical patients and non-THC products for CBD consumers. Kanabo has invested heavily in research and development to create high-quality cannabis oil formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions. These efforts are aimed at making cannabis use easy and accessible. The company operates in the medical cannabis market and serves patients requiring medical cannabis as well as consumers seeking CBD products. Kanabo's business model is unique in that it takes complete control of the process from research, through growth, to consumption, ensuring an innovative and precise product. The company generates revenue through the sale of its cannabis-derived products and medical devices. Located in the Weizmann Science Park in Israel, Kanabo's R&D lab is at the forefront of cannabis research, having developed a patent-pending sleep formula and conducted medical validation studies on its VapePod device. The VapePod is a cutting-edge vaporization device that includes metered dosing for accurate consumption, and it is the first medically certified vaporization delivery system for cannabis extracts. Kanabo continues to develop THC formulas for CNS disorders and non-THC formulas for the growing CBD market, combining consistent active ingredients, medical-grade precision, and clinical validation.

Keywords: medical cannabis, CBD products, cannabis oil, vaporizers, R&D, holistic ecosystem, VapePod, CNS disorders, sleep formula, Israel.